
In this episode, Dr. Ambreesh Chawla offers a preview of his upcoming ACR Convergence session exploring the complex relationship between medications and rheumatologic disease. He discusses unusual rheumatologic complications associated with commonly prescribed medications, including dupilumab-associated enthesitis, proton pump inhibitors (PPIs), and DPP-4 inhibitors. Through interactive cases and clinical scenarios, the session challenges clinicians to ask an important question: Is it disease, or is it drug? Dr. Chawla also shares insights into his journey from biomedical engineering to rheumatology, his passion for medical education, and how he makes the most of the ACR Convergence experience.
Weitere Episoden von „ACR Journals On Air“



Verpasse keine Episode von “ACR Journals On Air” und abonniere ihn in der kostenlosen GetPodcast App.








